A new sort of Alzheimer’s drug shows glimmers of promise

LONDON — An experimental drug can sweep tangles of tau from the brain, raising hopes that the treatment could help Alzheimer’s disease patients, according to clinical trial data released July 14.

The compound, called diranersen and developed by pharma giant Biogen, reduced tau…